Browse by Publication

Goel, G and Sun, W (2015) Novel approaches in the management of pancreatic ductal adenocarcinoma: Potential promises for the future. Journal of Hematology and Oncology, 8 (1).

Goel, G and Sun, W (2015) Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in second-line setting - Its impact on clinical practice. Journal of Hematology and Oncology, 8 (1).

Goel, G and Sun, W (2015) Advances in the management of gastrointestinal cancers - An upcoming role of immune checkpoint blockade. Journal of Hematology and Oncology, 8 (1).

Liu, D and Sun, W and Hou, J and Yuan, R and Li, Z (2015) Pass quantity, focus on quality. Journal of Hematology and Oncology, 8 (1).

Wu, Z and Zhang, X and Xu, X and Chen, Y and Hu, T and Kang, Z and Li, S and Wang, H and Liu, W and Ma, X and Guan, M (2014) The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Journal of Hematology and Oncology, 7 (1).

Wun, T and Soulieres, D and Frelinger, AL and Krishnamurti, L and Novelli, EM and Kutlar, A and Ataga, KI and Knupp, CL and McMahon, LE and Strouse, JJ and Zhou, C and Heath, LE and Nwachuku, CE and Jakubowski, JA and Riesmeyer, JS and Winters, KJ (2013) A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease. Journal of Hematology and Oncology, 6 (1).

Sun, W (2012) Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy. Journal of Hematology and Oncology, 5.

Jian, P and Li, ZW and Fang, TY and Jian, W and Zhuan, Z and Mei, LX and Yan, WS and Jian, N (2011) Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663. Journal of Hematology and Oncology, 4.